JP2025500465A5 - - Google Patents

Info

Publication number
JP2025500465A5
JP2025500465A5 JP2024538173A JP2024538173A JP2025500465A5 JP 2025500465 A5 JP2025500465 A5 JP 2025500465A5 JP 2024538173 A JP2024538173 A JP 2024538173A JP 2024538173 A JP2024538173 A JP 2024538173A JP 2025500465 A5 JP2025500465 A5 JP 2025500465A5
Authority
JP
Japan
Prior art keywords
seq
domain
sequence
epor
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024538173A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025500465A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2022/053359 external-priority patent/WO2023118878A1/en
Publication of JP2025500465A publication Critical patent/JP2025500465A/ja
Publication of JP2025500465A5 publication Critical patent/JP2025500465A5/ja
Pending legal-status Critical Current

Links

JP2024538173A 2021-12-22 2022-12-22 構成的サイトカイン受容体 Pending JP2025500465A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB202118797 2021-12-22
GB2118797.6 2021-12-22
PCT/GB2022/053359 WO2023118878A1 (en) 2021-12-22 2022-12-22 Constitutive cytokine receptors

Publications (2)

Publication Number Publication Date
JP2025500465A JP2025500465A (ja) 2025-01-09
JP2025500465A5 true JP2025500465A5 (cg-RX-API-DMAC7.html) 2025-12-10

Family

ID=84887911

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024538173A Pending JP2025500465A (ja) 2021-12-22 2022-12-22 構成的サイトカイン受容体

Country Status (7)

Country Link
EP (1) EP4453022A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025500465A (cg-RX-API-DMAC7.html)
CN (1) CN118434761A (cg-RX-API-DMAC7.html)
AU (1) AU2022422880A1 (cg-RX-API-DMAC7.html)
CA (1) CA3241186A1 (cg-RX-API-DMAC7.html)
TW (1) TW202334398A (cg-RX-API-DMAC7.html)
WO (1) WO2023118878A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024133472A1 (en) * 2022-12-22 2024-06-27 Quell Therapeutics Limited Constitutive cytokine receptors
CN117567643A (zh) * 2023-11-13 2024-02-20 四川大学 一种新型il-3受体修饰的嵌合抗原受体及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9803351D0 (en) 1998-02-17 1998-04-15 Oxford Biomedica Ltd Anti-viral vectors
WO1999067360A2 (en) * 1998-06-25 1999-12-29 Hemosol Inc. Media and methods for expansion of erythroid stem cells for the production of hemoglobin
GB0009760D0 (en) 2000-04-19 2000-06-07 Oxford Biomedica Ltd Method
JP5626164B2 (ja) 2011-07-26 2014-11-19 日本精工株式会社 ステアリングコラム用支持装置
WO2019055946A1 (en) * 2017-09-18 2019-03-21 F1 Oncology, Inc. METHODS AND COMPOSITIONS FOR THE GENETIC MODIFICATION AND EXPANSION OF LYMPHOCYTES AND THE REGULATION OF THE ACTIVITY THEREOF
AU2019227979B2 (en) 2018-03-02 2024-09-05 Allogene Therapeutics, Inc. Inducible chimeric cytokine receptors
WO2019241549A1 (en) 2018-06-15 2019-12-19 A2 Biotherapeutics, Inc. Foxp3-expressing car-t regulatory cells
JP7484712B2 (ja) 2018-06-29 2024-05-16 Agc株式会社 複合部材および成形用型、複合部材の製造方法およびガラス材料の成形方法ならびに光学素子の製造方法、光学系の製造方法、および撮像装置の製造方法
GB201814203D0 (en) 2018-08-31 2018-10-17 King S College London Engineered regulatory t cell
GB202007842D0 (en) 2020-05-26 2020-07-08 Quell Therapeutics Ltd Polypeptide useful in adoptive cell therapy

Similar Documents

Publication Publication Date Title
JP2022541657A5 (cg-RX-API-DMAC7.html)
US7638281B2 (en) Polypeptide, cDNA encoding the same and use of them
RU2010122053A (ru) Иммуносупрессорные полипептиды и нуклеиновые кислоты
MX2012002428A (es) Compuestos de union il-17 y usos medicos de los mismos.
JPH08507676A (ja) 可溶性オリゴマー蛋白質の調製法
CA2337100A1 (en) Polypeptides of lymphodendritic cell adhesion molecules (ldcams) and polynucleotides encoding the same
CA3140064A1 (en) Lockr-mediated recruitment of car t cells
JP2007519611A (ja) 分泌された三量体受容体類似体及び生物学的活性融合タンパク質を製造するための方法及び組成物
KR20190012193A (ko) 안정화된 융합-전 rsv f 단백질
JP3854995B2 (ja) 細胞透過性キャリアペプチド
EP1918297A1 (en) Neuronal differentiation-inducing peptide and use thereof
WO2024204896A1 (en) Genetically modified cells into which a nucleic acid encoding a stefin a protein variants specifically binding to tnfr2 or a fusion protein comprising the same has been introduced, and uses thereof
KR101064914B1 (ko) 자가면역질환, 알러지성 질환 및 염증성 질환 치료용 약제 조성물 및 이의 전달 방법
EP1809660A2 (en) A thymus-specific protein
AU2021219885B2 (en) Optimization of chimeric antigen receptor
JP2022049715A (ja) インスリン分泌促進ペプチド
CN117285645A (zh) 一种铁蛋白纳米颗粒疫苗的制备和应用
CN119285745B (zh) TGF-β受体激动剂多肽及其用途
CN119285746B (zh) 作为TGF-β受体激动剂肽的化合物及其用途
WO1999018205A1 (fr) POLYPEPTIDE, ADNc LE CODANT ET LEUR UTILISATION
JPH05508539A (ja) 安定および生体活性改変ソマトトロピン類
US9856293B2 (en) Methods for inducing nestin expression of astrocytes by nestin-inducing synthetic peptides derived from the BC-box of the SOCS6 protein
KR20250047619A (ko) Tnfr2 결합 에이전트를 인코딩하는 핵산을 포함하는 유전자 변형된 세포 및 이의 용도
AU2017358552B2 (en) Protransducine-C: gene transfer activator
TW202513793A (zh) 已經引入至有編碼特異性結合tnfr2的stefin a蛋白變體或包括該蛋白變體的融合蛋白的核酸中的經遺傳修飾的細胞,及其用途